These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8551028)
1. Cleavable CD40Ig fusion proteins and the binding to sgp39. Hollenbaugh D; Douthwright J; McDonald V; Aruffo A J Immunol Methods; 1995 Dec; 188(1):1-7. PubMed ID: 8551028 [TBL] [Abstract][Full Text] [Related]
2. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Aruffo A; Farrington M; Hollenbaugh D; Li X; Milatovich A; Nonoyama S; Bajorath J; Grosmaire LS; Stenkamp R; Neubauer M Cell; 1993 Jan; 72(2):291-300. PubMed ID: 7678782 [TBL] [Abstract][Full Text] [Related]
3. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells. Wykes M; Poudrier J; Lindstedt R; Gray D Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065 [TBL] [Abstract][Full Text] [Related]
4. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction. Bajorath J; Chalupny NJ; Marken JS; Siadak AW; Skonier J; Gordon M; Hollenbaugh D; Noelle RJ; Ochs HD; Aruffo A Biochemistry; 1995 Feb; 34(6):1833-44. PubMed ID: 7531493 [TBL] [Abstract][Full Text] [Related]
5. [Expression, purification and identification of fusion protein mTSLPR-Ig]. Zhang F; Shi Y; Huang G; Li ZL; Hu B; Song Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 May; 27(5):511-4. PubMed ID: 21557908 [TBL] [Abstract][Full Text] [Related]
6. Efficient generation of monoclonal antibodies for specific protein domains using recombinant immunoglobulin fusion proteins: pitfalls and solutions. Harris CL; Lublin DM; Morgan BP J Immunol Methods; 2002 Oct; 268(2):245-58. PubMed ID: 12215393 [TBL] [Abstract][Full Text] [Related]
7. Dimeric but not monomeric soluble CD40 prolongs allograft survival and generates regulatory T cells that inhibit CTL function. Masunaga T; Yamashita K; Sakihama H; Hashimoto T; Hua N; Imai A; Inobe M; Miyazaki T; Todo S; Uede T Transplantation; 2005 Dec; 80(11):1614-22. PubMed ID: 16371933 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis. Biancone L; Andres G; Ahn H; DeMartino C; Stamenkovic I Kidney Int; 1995 Aug; 48(2):458-68. PubMed ID: 7564113 [TBL] [Abstract][Full Text] [Related]
9. Bispecific receptor globulins, novel tools for the study of cellular interactions. Preparation and characterization of an E-selectin/P-selectin bispecific receptor globulin. Dietsch MT; Smith VF; Cosand WL; Damle NK; Ledbetter JA; Linsley PS; Aruffo A J Immunol Methods; 1993 Jun; 162(1):123-32. PubMed ID: 7685365 [TBL] [Abstract][Full Text] [Related]
10. A hingeless Fc fusion system for site-specific cleavage by IdeS. Novarra S; Grinberg L; Rickert KW; Barnes A; Wilson S; Baca M MAbs; 2016; 8(6):1118-25. PubMed ID: 27210548 [TBL] [Abstract][Full Text] [Related]
11. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells. Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. Kiener PA; Moran-Davis P; Rankin BM; Wahl AF; Aruffo A; Hollenbaugh D J Immunol; 1995 Nov; 155(10):4917-25. PubMed ID: 7594496 [TBL] [Abstract][Full Text] [Related]
13. Protective effect of human CD40-Ig fusion protein in a murine model of acute graft-versus-host disease. Liu H; Mao N; Hou C; Li X; Shen B; Tang PH Chin Med J (Engl); 2001 Jul; 114(7):685-9. PubMed ID: 11780327 [TBL] [Abstract][Full Text] [Related]
14. Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model. Angin M; Poirier N; Dilek N; Le Guiner C; Toromanoff A; Blancher A; Cherel Y; Deschamps JY; Tillou X; Renaudin K; Minault D; Hervouet J; Blancho G; Vanhove B; Anegon I; Le Mauff B Transpl Immunol; 2012 Dec; 27(4):139-45. PubMed ID: 23098770 [TBL] [Abstract][Full Text] [Related]
15. Detailed comparison of two molecular models of the human CD40 ligand with an x-ray structure and critical assessment of model-based mutagenesis and residue mapping studies. Bajorath J J Biol Chem; 1998 Sep; 273(38):24603-9. PubMed ID: 9733755 [TBL] [Abstract][Full Text] [Related]
16. Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis. Bajorath J; Marken JS; Chalupny NJ; Spoon TL; Siadak AW; Gordon M; Noelle RJ; Hollenbaugh D; Aruffo A Biochemistry; 1995 Aug; 34(31):9884-92. PubMed ID: 7543281 [TBL] [Abstract][Full Text] [Related]
17. Generation of soluble interleukin-1 receptor from an immunoadhesin by specific cleavage. Beck JT; Marsters SA; Harris RJ; Carter P; Ashkenazi A; Chamow SM Mol Immunol; 1994 Dec; 31(17):1335-44. PubMed ID: 7997245 [TBL] [Abstract][Full Text] [Related]
18. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites. Schaffer A; Cerutti A; Shah S; Zan H; Casali P J Immunol; 1999 May; 162(9):5327-36. PubMed ID: 10228008 [TBL] [Abstract][Full Text] [Related]
19. A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line. Vega MI; Santos-Argumedo L; Huerta-Yepez S; Luría-Perez R; Ortiz-Navarrete V; Isibasi A; González-Bonilla CR Immunology; 2003 Oct; 110(2):206-16. PubMed ID: 14511234 [TBL] [Abstract][Full Text] [Related]
20. Construction, purification, and characterization of new interferon gamma (IFN gamma) inhibitor proteins. Three IFN gamma receptor-immunoglobulin hybrid molecules. Kürschner C; Garotta G; Dembić Z J Biol Chem; 1992 May; 267(13):9354-60. PubMed ID: 1533630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]